This article only represents the author's own views.
The superficial story in the latest results for plastic surgery platform operator So-Young International Inc. (SY.US) was strong growth for topline revenue and even stronger gains for bottom line profits in the three months through June.
But the much bigger story was one that has dogged many of China’s fastest-growing emerging sectors since the middle of the year, namely the prospect of a looming regulatory crackdown. The broader series of crackdowns actually dates back to late last year with the spectacular 11th hour collapse of what was set to be a blockbuster IPO by fintech behemoth Ant Financial.
您已閱讀10%（658字），剩餘90%（5896字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。